🇺🇸 FDA
Pipeline program

Biological Therapies Sodium Ascorbate Solution 30 g in 100 mL Injection, SODIUM CHLORIDE

APHP200019

Phase 3 small_molecule active

Quick answer

Biological Therapies Sodium Ascorbate Solution 30 g in 100 mL Injection, SODIUM CHLORIDE for Patient with sepsis complicated by ARDS is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Patient with sepsis complicated by ARDS
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials